{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:23:54Z","timestamp":1763018634953,"version":"3.44.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.xphs.2023.11.006","type":"journal-article","created":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T20:44:29Z","timestamp":1700513069000},"page":"486-492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Breast Cancer Resistance Protein Limits Fetal Transfer of Tadalafil in Mice"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2388-2320","authenticated-orcid":false,"given":"Tomohiro","family":"Nishimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1469-4547","authenticated-orcid":false,"given":"Saki","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9829-8436","authenticated-orcid":false,"given":"Masatoshi","family":"Tomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.xphs.2023.11.006_bib0001","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrd893","article-title":"Phosphodiesterase 5 inhibitors: current status and potential applications","volume":"1","author":"Rotella","year":"2002","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"10.1016\/j.xphs.2023.11.006_bib0002","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2217\/WHE.14.32","article-title":"Management of hypertensive disorders in pregnancy","volume":"10","author":"Moussa","year":"2014","journal-title":"Women's Health"},{"issue":"4","key":"10.1016\/j.xphs.2023.11.006_bib0003","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.bpobgyn.2011.01.006","article-title":"Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy","volume":"25","author":"Hutcheon","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"11","key":"10.1016\/j.xphs.2023.11.006_bib0004","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1111\/j.1471-0528.2012.03430.x","article-title":"Sildenafil citrate improves perinatal outcome in fetuses from pre-eclamptic rats","volume":"119","author":"Herraiz","year":"2012","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.xphs.2023.11.006_bib0005","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/ajh\/hpx130","article-title":"Tadalafil improves L-NG-nitroarginine methyl ester-induced preeclampsia with fetal growth restriction-like symptoms in pregnant mice","volume":"31","author":"Yoshikawa","year":"2017","journal-title":"Am J Hypertens"},{"issue":"3","key":"10.1016\/j.xphs.2023.11.006_bib0006","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.bbrc.2019.10.186","article-title":"Tadalafil alleviates preeclampsia and fetal growth restriction in RUPP model of preeclampsia in mice","volume":"521","author":"Sekimoto","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.xphs.2023.11.006_bib0007","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ajog.2020.01.025","article-title":"Safety and efficacy of sildenafil citrate to reduce operative birth for intrapartum fetal compromise at term: a phase 2 randomized controlled trial","volume":"222","author":"Turner","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.xphs.2023.11.006_bib0008","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S2352-4642(17)30173-6","article-title":"Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial","volume":"2","author":"Sharp","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"issue":"3","key":"10.1016\/j.xphs.2023.11.006_bib0009","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/uog.19186","article-title":"Clinicians should stop prescribing sildenafil for fetal growth restriction (FGR): comment from the STRIDER consortium","volume":"52","author":"Groom","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.xphs.2023.11.006_bib0010","doi-asserted-by":"crossref","first-page":"k3247","DOI":"10.1136\/bmj.k3247","article-title":"Trial of Viagra for fetal growth restriction is halted after baby deaths","volume":"362","author":"Hawkes","year":"2018","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.xphs.2023.11.006_bib0011","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3390\/jcm8060856","article-title":"Safety evaluation of tadalafil treatment for fetuses with early-onset growth restriction (TADAFER): results from the phase II trial","volume":"8","author":"Maki","year":"2019","journal-title":"J Clin Med"},{"issue":"22","key":"10.1016\/j.xphs.2023.11.006_bib0012","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1080\/14767058.2019.1690447","article-title":"Tadalafil treatment for preeclampsia (medication in preeclampsia; MIE): a multicenter phase II clinical trial","volume":"34","author":"Furuhashi","year":"2021","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"1","key":"10.1016\/j.xphs.2023.11.006_bib0013","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/HYPERTENSIONAHA.117.10738","article-title":"Evaluation of sildenafil and tadalafil for reversing constriction of fetal arteries in a human placenta perfusion model","volume":"72","author":"Walton","year":"2018","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.xphs.2023.11.006_bib0014","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3109\/1061186X.2012.716847","article-title":"Pharmacotherapy in pregnancy; effect of ABC and SLC transporters on drug transport across the placenta and fetal drug exposure","volume":"20","author":"Staud","year":"2012","journal-title":"J Drug Target"},{"issue":"7","key":"10.1016\/j.xphs.2023.11.006_bib0015","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s11095-022-03165-6","article-title":"Limited impact of murine placental MDR1 on fetal exposure of certain drugs explained by bypass transfer between adjacent syncytiotrophoblast layers","volume":"39","author":"Fujita","year":"2022","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2023.11.006_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fddev.2022.932576","article-title":"Quantitative Comparison of Breast Cancer Resistance Protein (BCRP\/ABCG2) expression and function between maternal blood-brain barrier and placental barrier in mice at different gestational ages","volume":"2","author":"Fujita","year":"2022","journal-title":"Front Drug Deliv"},{"key":"10.1016\/j.xphs.2023.11.006_bib0017","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1124\/dmd.120.000067","article-title":"Gestational age-dependent abundance of human placental transporters as determined by quantitative targeted proteomics","volume":"48","author":"Anoshchenko","year":"2020","journal-title":"Drug Metab Dispos"},{"issue":"S1","key":"10.1016\/j.xphs.2023.11.006_bib0018","first-page":"70","article-title":"Drug transporters expressed in the human placenta and models for studying maternal-fetal drug transfer","volume":"2019","author":"Dallmann","year":"2019","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.xphs.2023.11.006_bib0019","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/BF00160054","article-title":"Stage-specific distribution of P-glycoprotein in first-trimester and full-term human placenta","volume":"26","author":"Macfarland","year":"1994","journal-title":"Histochem J"},{"key":"10.1016\/j.xphs.2023.11.006_bib0020","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.reprotox.2016.09.002","article-title":"Layer II of placental syncytiotrophoblasts expresses MDR1 and BCRP at the apical membrane in rodents","volume":"65","author":"Akashi","year":"2016","journal-title":"Reprod Toxicol"},{"issue":"8","key":"10.1016\/j.xphs.2023.11.006_bib0021","first-page":"3458","article-title":"Subcellular localization and distribution of the Breast Resistance Protein Transporter in normal human tissues","volume":"61","author":"Maliepaard","year":"2001","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.xphs.2023.11.006_bib0022","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1124\/dmd.106.011411","article-title":"Organic anion transporting polypeptide 2B1 and breast cancer resistance protein interact in the transepithelial transport of steroid sulfates in human placenta","volume":"35","author":"Grube","year":"2007","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1016\/j.xphs.2023.11.006_bib0023","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.placenta.2012.01.008","article-title":"Placental drug transporters and their role in fetal protection","volume":"33","author":"Iqbal","year":"2012","journal-title":"Placenta"},{"issue":"8","key":"10.1016\/j.xphs.2023.11.006_bib0024","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.2042-7158.2012.01498.x","article-title":"Characterization of efflux transport of the PDE5 inhibitors, vardenafil and sildenafil","volume":"64","author":"Choi","year":"2012","journal-title":"J Pharm Pharmacol"},{"issue":"8","key":"10.1016\/j.xphs.2023.11.006_bib0025","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1248\/bpb.b17-00278","article-title":"In vitro P-glycoprotein-mediated transport of tadalafil: a comparison with sildenafil","volume":"40","author":"Higashi","year":"2017","journal-title":"Biol Pharm Bull"},{"issue":"8","key":"10.1016\/j.xphs.2023.11.006_bib0026","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.ejca.2012.12.028","article-title":"Sildenafil is not a useful modulator of ABCB1 and ABCG2 mediated drug resistance in vivo","volume":"49","author":"Lin","year":"2013","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.xphs.2023.11.006_bib0027","doi-asserted-by":"crossref","DOI":"10.1080\/10826070500479393","article-title":"Determination of sildenafil, tadalafil, and vardenafil in tablets and adulterated herbal products by ESI-MS-MS","volume":"29","author":"Abdel-Hamid","year":"2006","journal-title":"J Liq Chromatogr Relat Technol"},{"issue":"3","key":"10.1016\/j.xphs.2023.11.006_bib0028","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/004982599238687","article-title":"Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man","volume":"29","author":"Walker","year":"1999","journal-title":"Xenobiotica"},{"issue":"3","key":"10.1016\/j.xphs.2023.11.006_bib0029","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s12640-018-9876-4","article-title":"Effect of tadalafil on seizure threshold and activity of antiepileptic drugs in three acute seizure tests in mice","volume":"34","author":"Soca\u0142a","year":"2018","journal-title":"Neurotox Res"},{"issue":"1","key":"10.1016\/j.xphs.2023.11.006_bib0030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0012-1606(84)90174-X","article-title":"Differential expression of albumin and \u03b1-fetoprotein genes in fetal tissues of mouse and rat","volume":"102","author":"Sellem","year":"1984","journal-title":"Dev Biol"},{"issue":"10","key":"10.1016\/j.xphs.2023.11.006_bib0031","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-020-02895-9","article-title":"Characterization and validation of canine P-glycoprotein-deficient MDCK II cell lines for efflux substrate screening","volume":"37","author":"Ye","year":"2020","journal-title":"Pharm Res"},{"issue":"17","key":"10.1016\/j.xphs.2023.11.006_bib0032","first-page":"4237","article-title":"The mouse Bcrp1\/Mxr\/Abcp gene: amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin","volume":"59","author":"Allen","year":"1999","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.xphs.2023.11.006_bib0033","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s004410050623","article-title":"Immunolocalization of GLUT1 and connexin 26 in the rat placenta","volume":"285","author":"Shin","year":"1996","journal-title":"Cell Tissue Res"},{"issue":"5","key":"10.1016\/j.xphs.2023.11.006_bib0034","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.3109\/10717544.2015.1077291","article-title":"Transdermal delivery of tadalafil using a novel formulation","volume":"23","author":"Baek","year":"2016","journal-title":"Drug Deliv"},{"key":"10.1016\/j.xphs.2023.11.006_bib0035","unstructured":"Calculated using Advanced Chemistry Development (ACD\/Labs) Software V11.02 (\u00a9 1994-2023 ACD\/Labs) retrieved from https:\/\/scifinder-n.cas.org\/."},{"issue":"1\u20132","key":"10.1016\/j.xphs.2023.11.006_bib0036","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ijpharm.2007.10.039","article-title":"Mechanistic analysis of pH-dependent solubility and trans-membrane permeability of amphoteric compounds: application to sildenafil","volume":"352","author":"Wang","year":"2008","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2023.11.006_bib0037","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1248\/bpb.b14-00566","article-title":"Contribution of CYP3A isoforms to dealkylation of PDE5 inhibitors: a comparison between sildenafil N-demethylation and tadalafil demethylenation","volume":"38","author":"Takahiro","year":"2015","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.xphs.2023.11.006_bib0038","first-page":"673","article-title":"Neonatal cytochrome P450 CYP3A7: a comprehensive review of its role in development, disease, and xenobiotic metabolism","author":"Li","year":"2019","journal-title":"Arch Biochem Biophys"},{"year":"2017","series-title":"U.S. Food and Drug Administration","key":"10.1016\/j.xphs.2023.11.006_bib0039"},{"year":"2017","series-title":"Tadalafil [Package Insert]","key":"10.1016\/j.xphs.2023.11.006_bib0040"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235492300480X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235492300480X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:43:46Z","timestamp":1758361426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235492300480X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S002235492300480X"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2023.11.006","relation":{},"ISSN":["0022-3549"],"issn-type":[{"type":"print","value":"0022-3549"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breast Cancer Resistance Protein Limits Fetal Transfer of Tadalafil in Mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2023.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of American Pharmacists Association.","name":"copyright","label":"Copyright"}]}}